ViroGates AS (OCSE:VIRO) Total Operating Expense: kr17.66 Mil (TTM As of Mar. 2026)


OCSE:VIRO ViroGates AS OCSE:VIRO
44 GF Score
Price kr10.20
GF Value kr6.75
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS Total Operating Expense?

ViroGates AS OCSE:VIRO 44 Total Operating Expense is kr17.66 Mil as of Mar. 2026. GuruFocus rates OCSE:VIRO with a GF Score™ of 44/100 and a GF Value™ of kr6.75 (Significantly Overvalued). The stock has 2 warning signs investors should review.

ViroGates AS's Total Operating Expense for the three months ended in Mar. 2026 was kr3.85 Mil. ViroGates AS's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr17.66 Mil.

ViroGates AS Total Operating Expense Related Terms

ViroGates AS Total Operating Expense Historical Data

* Premium members only.

The historical data trend for ViroGates AS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViroGates AS Total Operating Expense Chart

ViroGates AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.17 23.50 18.37 19.37 17.09

ViroGates AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.29 6.20 3.09 4.52 3.85
OCSE:VIRO
44GF Score
ViroGates AS OCSE:VIRO
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ViroGates AS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr17.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of kr17.66 Mil mean?
ViroGates AS (OCSE:VIRO) has a Total Operating Expense of kr17.66 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on ViroGates AS and its competitors.
Is ViroGates AS's Total Operating Expense too high?
ViroGates AS's current Total Operating Expense is kr17.66 Mil. Overall, ViroGates AS has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ViroGates AS's Total Operating Expense compare to ABT and SYK?
ViroGates AS's Total Operating Expense of kr17.66 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on ViroGates AS and its competitors. ViroGates AS's current Total Operating Expense is kr17.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViroGates AS stock overvalued right now?
Based on GuruFocus' analysis, ViroGates AS (OCSE:VIRO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr6.75, compared to a current price of kr10.20 — trading 51.1% above its estimated fair value. The current Total Operating Expense is kr17.66 Mil. ViroGates AS's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For ViroGates AS (OCSE:VIRO), the current Total Operating Expense is kr17.66 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ViroGates AS (OCSE:VIRO) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of kr10.20 is trading 51.1% above its estimated GF Value™ of kr6.75. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for OCSE:VIRO:

  • Total Operating Expense: kr17.66 Mil
  • GF Value™: kr6.75 vs. price of kr10.20 (51.1% above fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the OCSE:VIRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ViroGates AS Business Description

Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
44GF Score

Get the complete analysis for OCSE:VIRO

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.20
Price
kr6.75
GF Value